These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38674108)

  • 1. Profiling of Tumour-Infiltrating Lymphocytes and Tumour-Associated Macrophages in Ovarian Epithelial Cancer-Relation to Tumour Characteristics and Impact on Prognosis.
    Stout A; Facey N; Bhatnagar A; Rice K; Berditchevski F; Kearns D; Metcalf A; Elghobashy A; Shaaban AM
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancer.
    James FR; Jiminez-Linan M; Alsop J; Mack M; Song H; Brenton JD; Pharoah PDP; Ali HR
    BMC Cancer; 2017 Sep; 17(1):657. PubMed ID: 28931370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical profiling of the tumour microenvironment in borderline and malignant ovarian tumours in young women.
    O'Neill D; Rice K; Bhatnagar A; Kearns D; Berditchevski F; El-Ghobashy A; Shaaban AM
    Oncol Lett; 2023 May; 25(5):177. PubMed ID: 37033098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer.
    Ojalvo LS; Thompson ED; Wang TL; Meeker AK; Shih IM; Fader AN; Cimino-Mathews A; Emens LA
    Hum Pathol; 2018 Apr; 74():135-147. PubMed ID: 29288043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High density of stroma-localized CD11c-positive macrophages is associated with longer overall survival in high-grade serous ovarian cancer.
    Corvigno S; Mezheyeuski A; De La Fuente LM; Westbom-Fremer S; Carlson JW; Fernebro J; Åvall-Lundqvist E; Kannisto P; Hedenfalk I; Malander S; Rolny C; Dahlstrand H; Östman A
    Gynecol Oncol; 2020 Dec; 159(3):860-868. PubMed ID: 33032823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the tumour microenvironment mark the transition from serous borderline tumour to low-grade serous carcinoma.
    Vallejos R; Zhantuyakova A; Negri GL; Martin SD; Spencer SE; Thornton S; Leung S; Lynch B; Qin Y; Chow C; Liang B; Zdravko S; Douglas JM; Milne K; Mateyko B; Nelson BH; Howitt BE; Kommoss FK; Horn LC; Hoang L; Singh N; Morin GB; Huntsman DG; Cochrane D
    J Pathol; 2024 Oct; 264(2):197-211. PubMed ID: 39081243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution pattern of tumor infiltrating lymphocytes and tumor microenvironment composition as prognostic indicators in anorectal malignant melanoma.
    Kim SW; Kim YI; Mustafa B; Kim MJ; Jeong G; Ahn SM; Lim SB; Yu CS; Kim JC; Hong SM; Park IJ
    Mod Pathol; 2021 Jan; 34(1):141-160. PubMed ID: 32709987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance.
    Althobiti M; Aleskandarany MA; Joseph C; Toss M; Mongan N; Diez-Rodriguez M; Nolan CC; Ashankyty I; Ellis IO; Green AR; Rakha EA
    Histopathology; 2018 Dec; 73(6):887-896. PubMed ID: 29947077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotyping in tubo-ovarian high-grade serous carcinoma by PD-L1 and CD8+ T-lymphocytes predicts disease-free survival.
    Bansal A; Srinivasan R; Rohilla M; Rai B; Rajwanshi A; Suri V; Chandra Saha S
    APMIS; 2021 May; 129(5):254-264. PubMed ID: 33455015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of immunoreactivity with whole-slide imaging and digital analysis in high-grade serous ovarian cancer.
    Jäntti T; Luhtala S; Mäenpää J; Staff S
    Tumour Biol; 2020 Nov; 42(11):1010428320971404. PubMed ID: 33169632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer.
    Bösmüller HC; Wagner P; Peper JK; Schuster H; Pham DL; Greif K; Beschorner C; Rammensee HG; Stevanović S; Fend F; Staebler A
    Int J Gynecol Cancer; 2016 May; 26(4):671-9. PubMed ID: 26905331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell density and location can influence the prognosis of ovarian cancer.
    Al-Attar A; Shehata M; Durrant L; Moseley P; Deen S; Chan S
    Pathol Oncol Res; 2010 Sep; 16(3):361-70. PubMed ID: 20024633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for Immunotherapy.
    Lo CS; Sanii S; Kroeger DR; Milne K; Talhouk A; Chiu DS; Rahimi K; Shaw PA; Clarke BA; Nelson BH
    Clin Cancer Res; 2017 Feb; 23(4):925-934. PubMed ID: 27601594
    [No Abstract]   [Full Text] [Related]  

  • 14. Patient inflammatory status and CD4+/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer.
    Pinto MP; Balmaceda C; Bravo ML; Kato S; Villarroel A; Owen GI; Roa JC; Cuello MA; Ibañez C
    Gynecol Oncol; 2018 Oct; 151(1):10-17. PubMed ID: 30078505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraepithelial T cells and tumor-associated macrophages in ovarian cancer patients.
    Mhawech-Fauceglia P; Wang D; Ali L; Lele S; Huba MA; Liu S; Odunsi K
    Cancer Immun; 2013; 13():1. PubMed ID: 23390372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast.
    Rathore AS; Kumar S; Konwar R; Makker A; Negi MP; Goel MM
    Indian J Med Res; 2014 Sep; 140(3):361-9. PubMed ID: 25366203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
    Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes.
    Stumpf M; Hasenburg A; Riener MO; Jütting U; Wang C; Shen Y; Orlowska-Volk M; Fisch P; Wang Z; Gitsch G; Werner M; Lassmann S
    Br J Cancer; 2009 Nov; 101(9):1513-21. PubMed ID: 19861998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor immune microenvironment changes are associated with response to neoadjuvant chemotherapy and long-term survival benefits in advanced epithelial ovarian cancer: A pilot study.
    Cao G; Hua D; Li J; Zhang X; Zhang Z; Zhang B; Bei T; Cui L; Chen S; Wang S; Zhu L
    Front Immunol; 2023; 14():1022942. PubMed ID: 36993949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes.
    Ardighieri L; Missale F; Bugatti M; Gatta LB; Pezzali I; Monti M; Gottardi S; Zanotti L; Bignotti E; Ravaggi A; Tognon G; Odicino F; Calza S; Missolo-Koussou Y; Ries CH; Helft J; Vermi W
    Front Immunol; 2021; 12():690201. PubMed ID: 34220848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.